Posted in | News | Iron Ore | Mining Business

Fairmont Enters Option Agreement with ElanOre for 40% Interest in Lac Elan Ilmenite-Magnetite Property

Fairmont Resources Inc. is pleased to announce that it has signed a definitive option agreement with ElanOre Resources Inc. to option a 40% Interest in the Lac Elan Property (the "Property").

Lac Elan Ilmenite-Magnetite Property Option Agreement

To acquire 40% of the Property, Fairmont will issue 1,000,000 shares within 5 days of the TSX Venture Exchange's ("TSXV") final approval. Fairmont must also spend $100,000 in exploration or development expenditures on the property within 24 months of the effective date of the option agreement, with a minimum $25,000 being incurred before the first anniversary of the effective date of the option agreement, and the balance before the second anniversary of the effective date of the option agreement. The 388.5 sq km Lac Elan property, located near Saguenay, Quebec, was staked between 2009 and 2011. Surface sampling, trenching and prospecting have produced consistent iron and titanium analysis over a considerable strike length with values up to 56.88% Fe2O3, 16.93% TiO2, and 0.42% V2O5 over 18.5 meters in trench sampling.

Commenting on the Lac Elan Property, Michael Dehn, President and CEO, said, "The option of the lac Elan Property is a result of Fairmont's expertise identifying opportunities in commodities often overlooked by the others. Lac Elan provides Fairmont with a strong asset to build a small, valuable resource that is close to infrastructure in Quebec."

Source: http://www.fairmontresources.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.